Latest Breaking News On - Philippe dubuc - Page 4 : comparemela.com

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Christian marsolaisStefan klotterPhilippe dubucJulie schneidermanDrug administrationTheratechnologies incCommunications corporate affairsComplete response letterBiologics license applicationSenior vice presidentChief medical officerForward looking statementsLooking statementsAnnual information formVice presidentChief financial

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesJulie schneidermanPhilippe dubucChristian marsolaisCommunications corporate affairsIntramuscular im method of administrationDrug administrationCompany labelling prior approvalTheratechnologies incBiologics license applicationUnited states foodLabelling prior approval supplementSenior vice presidentChief medical officerPrescription drug user fee actSodium chloride injection

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesPhilippe dubucJulie schneidermanChristian marsolaisDrug administrationCommunications corporate affairsTheratechnologies incCompany labelling prior approvalBiologics license applicationUnited states foodLabelling prior approval supplementSenior vice presidentChief medical officerPrescription drug user fee actSodium chloride injectionForward looking statements

THERATECHNOLOGIES : INVESTISSEMENT QUÉBEC INVESTOR RIGHTS AGREEMENT - Form 6-K -November 06, 2023 at 12:31 pm EST

THERATECHNOLOGIES INC. - and - INVESTISSEMENT QUÉBEC INVESTOR RIGHTS AGREEMENT October 31,.

United statesJean pierre chamberlandHadrien montagneIsabelle nazonPhilippe dubucMonica dingleNo partyCorporation in quToronto stock exchangeHead officeFasken martineau dumoulinShareholders of the corporationCorporation sociBoard of directors the corporationCorporate governance committeeShareholder approval for exchange of subscription receipts

Theratechnologies : FIRST AMENDMENT TO CREDIT AGREEMENT - Form 6-K -November 03, 2023 at 02:30 pm EDT

FIRST AMENDMENT TO CREDIT AGREEMENT This FIRST AMENDMENT TO CREDIT AGREEMENT is made and entered into as of February 27, 2023 by and among THERATECHNOLOGIES.

United statesLou hanoverPhilippe dubucUs bank trust companyMarathon healthcare finance fundTiger lenderSloan partyBusiness corporations actTrust companyRequired lendersSubscription agreementLoan partiesControl agreementsCash equivalent investmentsPermitted government securitiesEffective date